Can-Fite BioPharma Inc. (CANF) stock soars during current market. Why so?
Can-Fite BioPharma Inc. (NASDAQ: CANF) stock gained by 4.42% in the current market trading session. Can-Fite BioPharma Ltd. is a medication research company in advanced clinical stages with a platform technology targeted to address multi-billion dollar markets in cancer, liver, inflammatory illness, and COVID-19. What’s new? Can-Fite BioPharma, a biotechnology company located in Israel, is […]